Cite
HARVARD Citation
Paul, R. et al. (n.d.). INVOKE‐2: A phase 2 randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of AL002 in participants with early Alzheimer's disease. Alzheimer's & dementia. p. n/a. [Online].